MW
Mats Wahlstrom

Mats Wahlstrom insider trades: Coherus Oncology (CHRS) stock buys and sales

Coherus Oncology Last trade May 23, 2025 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2015
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mats reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 23, 2025CHRS↓ Sell$74K
Nov 22, 2024TLSI↑ Buy$23K
Nov 21, 2024TLSI↑ Buy$47K
Jun 17, 2020CHRS↓ Sell$3.4M
Mar 3, 2020CHRS↓ Sell$2.4M
Dec 8, 2016CHRS↓ Sell$1.5M
Aug 18, 2015CHRS↓ Sell$214K
Aug 17, 2015CHRS↓ Sell$272K
Aug 14, 2015CHRS↓ Sell$4.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Mats Wahlstrom's insider trades

Mats Wahlstrom is an insider at Coherus Oncology (CHRS). Since Aug 14, 2015, Mats has reported 2 open-market purchases worth $70K and 7 sales worth $11.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (21 filings), other transactions (6 filings), option exercises (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CHRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.